CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: DRUG DISCOVERY OUTSOURCING MARKET, BY WORKFLOW
4.1 Overview
4.1.1 Market size and forecast
4.2 Target Identification and Screening
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Target Validation and Functional Informatics
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4 Lead Identification and Candidate Optimization
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
4.5 Preclinical Development
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market share analysis by country
4.6 Others
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market share analysis by country
CHAPTER 5: DRUG DISCOVERY OUTSOURCING MARKET, BY THERAPEUTIC AREA
5.1 Overview
5.1.1 Market size and forecast
5.2 Respiratory system
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Infectious disease
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4 Oncology
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5 Immunology
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country
5.6 Hematology
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market share analysis by country
5.7 Cardiovascular
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market share analysis by country
5.8 Central Nervous System (CNS)
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market share analysis by country
5.9 Gastrointestinal
5.9.1 Key market trends, growth factors and opportunities
5.9.2 Market size and forecast, by region
5.9.3 Market share analysis by country
6.0 Others
6.0.1 Key market trends, growth factors and opportunities
6.0.2 Market size and forecast, by region
6.0.3 Market share analysis by country
CHAPTER 6: DRUG DISCOVERY OUTSOURCING MARKET, BY DRUG TYPE
6.1 Overview
6.1.1 Market size and forecast
6.2 Small Molecules
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Large Molecules
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
CHAPTER 7: DRUG DISCOVERY OUTSOURCING MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Pharmaceutical and Biotechnology companies
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market share analysis by country
7.3 Academic Institutes
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market share analysis by country
7.4 Others
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market share analysis by country
CHAPTER 8: DRUG DISCOVERY OUTSOURCING MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Workflow
8.2.3 North America Market size and forecast, by Therapeutic area
8.2.4 North America Market size and forecast, by Drug Type
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Key market trends, growth factors and opportunities
8.2.6.1.2 Market size and forecast, by Workflow
8.2.6.1.3 Market size and forecast, by Therapeutic area
8.2.6.1.4 Market size and forecast, by Drug Type
8.2.6.1.5 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Key market trends, growth factors and opportunities
8.2.6.2.2 Market size and forecast, by Workflow
8.2.6.2.3 Market size and forecast, by Therapeutic area
8.2.6.2.4 Market size and forecast, by Drug Type
8.2.6.2.5 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Key market trends, growth factors and opportunities
8.2.6.3.2 Market size and forecast, by Workflow
8.2.6.3.3 Market size and forecast, by Therapeutic area
8.2.6.3.4 Market size and forecast, by Drug Type
8.2.6.3.5 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Workflow
8.3.3 Europe Market size and forecast, by Therapeutic area
8.3.4 Europe Market size and forecast, by Drug Type
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Key market trends, growth factors and opportunities
8.3.6.1.2 Market size and forecast, by Workflow
8.3.6.1.3 Market size and forecast, by Therapeutic area
8.3.6.1.4 Market size and forecast, by Drug Type
8.3.6.1.5 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Key market trends, growth factors and opportunities
8.3.6.2.2 Market size and forecast, by Workflow
8.3.6.2.3 Market size and forecast, by Therapeutic area
8.3.6.2.4 Market size and forecast, by Drug Type
8.3.6.2.5 Market size and forecast, by End User
8.3.6.3 UK
8.3.6.3.1 Key market trends, growth factors and opportunities
8.3.6.3.2 Market size and forecast, by Workflow
8.3.6.3.3 Market size and forecast, by Therapeutic area
8.3.6.3.4 Market size and forecast, by Drug Type
8.3.6.3.5 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Key market trends, growth factors and opportunities
8.3.6.4.2 Market size and forecast, by Workflow
8.3.6.4.3 Market size and forecast, by Therapeutic area
8.3.6.4.4 Market size and forecast, by Drug Type
8.3.6.4.5 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Key market trends, growth factors and opportunities
8.3.6.5.2 Market size and forecast, by Workflow
8.3.6.5.3 Market size and forecast, by Therapeutic area
8.3.6.5.4 Market size and forecast, by Drug Type
8.3.6.5.5 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Key market trends, growth factors and opportunities
8.3.6.6.2 Market size and forecast, by Workflow
8.3.6.6.3 Market size and forecast, by Therapeutic area
8.3.6.6.4 Market size and forecast, by Drug Type
8.3.6.6.5 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Workflow
8.4.3 Asia-Pacific Market size and forecast, by Therapeutic area
8.4.4 Asia-Pacific Market size and forecast, by Drug Type
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Key market trends, growth factors and opportunities
8.4.6.1.2 Market size and forecast, by Workflow
8.4.6.1.3 Market size and forecast, by Therapeutic area
8.4.6.1.4 Market size and forecast, by Drug Type
8.4.6.1.5 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Key market trends, growth factors and opportunities
8.4.6.2.2 Market size and forecast, by Workflow
8.4.6.2.3 Market size and forecast, by Therapeutic area
8.4.6.2.4 Market size and forecast, by Drug Type
8.4.6.2.5 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Key market trends, growth factors and opportunities
8.4.6.3.2 Market size and forecast, by Workflow
8.4.6.3.3 Market size and forecast, by Therapeutic area
8.4.6.3.4 Market size and forecast, by Drug Type
8.4.6.3.5 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Key market trends, growth factors and opportunities
8.4.6.4.2 Market size and forecast, by Workflow
8.4.6.4.3 Market size and forecast, by Therapeutic area
8.4.6.4.4 Market size and forecast, by Drug Type
8.4.6.4.5 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Key market trends, growth factors and opportunities
8.4.6.5.2 Market size and forecast, by Workflow
8.4.6.5.3 Market size and forecast, by Therapeutic area
8.4.6.5.4 Market size and forecast, by Drug Type
8.4.6.5.5 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Key market trends, growth factors and opportunities
8.4.6.6.2 Market size and forecast, by Workflow
8.4.6.6.3 Market size and forecast, by Therapeutic area
8.4.6.6.4 Market size and forecast, by Drug Type
8.4.6.6.5 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Workflow
8.5.3 LAMEA Market size and forecast, by Therapeutic area
8.5.4 LAMEA Market size and forecast, by Drug Type
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Key market trends, growth factors and opportunities
8.5.6.1.2 Market size and forecast, by Workflow
8.5.6.1.3 Market size and forecast, by Therapeutic area
8.5.6.1.4 Market size and forecast, by Drug Type
8.5.6.1.5 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Key market trends, growth factors and opportunities
8.5.6.2.2 Market size and forecast, by Workflow
8.5.6.2.3 Market size and forecast, by Therapeutic area
8.5.6.2.4 Market size and forecast, by Drug Type
8.5.6.2.5 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Key market trends, growth factors and opportunities
8.5.6.3.2 Market size and forecast, by Workflow
8.5.6.3.3 Market size and forecast, by Therapeutic area
8.5.6.3.4 Market size and forecast, by Drug Type
8.5.6.3.5 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Key market trends, growth factors and opportunities
8.5.6.4.2 Market size and forecast, by Workflow
8.5.6.4.3 Market size and forecast, by Therapeutic area
8.5.6.4.4 Market size and forecast, by Drug Type
8.5.6.4.5 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 . Charles River Laboratories,
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Curia Global Inc
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Dr. Reddy’s Laboratories
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Dalton Pharma Service
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Discover X Corporation
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Laboratory Corporation of America Holdings
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Merck & Co
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Syngene International Ltd
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Thermo Fisher Scientific, Inc.
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 TCG Life Science Pvt. Ltd
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
